EE03353B1 - Kristalne 5-atseetamido-2,3,4,5-tetradesoksü-4-guanidino-D-glütsero-D-galaktonon-2-eenpüranosoonh ape, selle valmistamismeetod ja seda sisaldavad farmatseutilised preparaadid - Google Patents

Kristalne 5-atseetamido-2,3,4,5-tetradesoksü-4-guanidino-D-glütsero-D-galaktonon-2-eenpüranosoonh ape, selle valmistamismeetod ja seda sisaldavad farmatseutilised preparaadid

Info

Publication number
EE03353B1
EE03353B1 EE9600135A EE9600135A EE03353B1 EE 03353 B1 EE03353 B1 EE 03353B1 EE 9600135 A EE9600135 A EE 9600135A EE 9600135 A EE9600135 A EE 9600135A EE 03353 B1 EE03353 B1 EE 03353B1
Authority
EE
Estonia
Prior art keywords
tetradesoxy
galactonone
glycero
guanidino
acetamido
Prior art date
Application number
EE9600135A
Other languages
English (en)
Inventor
Williamson Christopher
James White William
Patel Vipulkumar
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Publication of EE03353B1 publication Critical patent/EE03353B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EE9600135A 1993-12-17 1994-12-15 Kristalne 5-atseetamido-2,3,4,5-tetradesoksü-4-guanidino-D-glütsero-D-galaktonon-2-eenpüranosoonh ape, selle valmistamismeetod ja seda sisaldavad farmatseutilised preparaadid EE03353B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939325841A GB9325841D0 (en) 1993-12-17 1993-12-17 Chemical compounds
PCT/EP1994/004154 WO1995016680A1 (en) 1993-12-17 1994-12-15 Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation

Publications (1)

Publication Number Publication Date
EE03353B1 true EE03353B1 (et) 2001-02-15

Family

ID=10746778

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600135A EE03353B1 (et) 1993-12-17 1994-12-15 Kristalne 5-atseetamido-2,3,4,5-tetradesoksü-4-guanidino-D-glütsero-D-galaktonon-2-eenpüranosoonh ape, selle valmistamismeetod ja seda sisaldavad farmatseutilised preparaadid

Country Status (44)

Country Link
US (2) US6294572B1 (et)
EP (1) EP0734382B1 (et)
JP (1) JP3317972B2 (et)
KR (1) KR100403256B1 (et)
CN (2) CN1502621A (et)
AP (2) AP9600810A0 (et)
AT (1) ATE199255T1 (et)
BG (1) BG63338B1 (et)
BR (2) BR9408340A (et)
CA (1) CA2177990C (et)
CO (1) CO4340619A1 (et)
CZ (1) CZ289234B6 (et)
DE (1) DE69426726T2 (et)
DK (1) DK0734382T3 (et)
EE (1) EE03353B1 (et)
EG (1) EG20597A (et)
ES (1) ES2155517T3 (et)
FI (1) FI120453B (et)
GB (1) GB9325841D0 (et)
GR (1) GR3035681T3 (et)
HK (1) HK1014187A1 (et)
HR (1) HRP941001B1 (et)
HU (1) HU221971B1 (et)
IL (1) IL112011A (et)
IS (1) IS4240A (et)
MA (1) MA23396A1 (et)
MY (1) MY116221A (et)
NO (1) NO314759B1 (et)
NZ (1) NZ277789A (et)
OA (2) OA10325A (et)
PE (1) PE31095A1 (et)
PL (1) PL186384B1 (et)
PT (1) PT734382E (et)
RO (1) RO114792B1 (et)
RU (1) RU2134690C1 (et)
SA (1) SA94150417B1 (et)
SG (1) SG46669A1 (et)
SI (1) SI0734382T1 (et)
SK (1) SK282972B6 (et)
SV (1) SV1994000076A (et)
TW (1) TW452577B (et)
UA (1) UA46723C2 (et)
WO (1) WO1995016680A1 (et)
ZA (1) ZA9410003B (et)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
HU228450B1 (en) 1995-02-27 2013-03-28 Gilead Sciences Inc Novel selective inhibitors of viral or bacterial neuraminidases
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
EP0823428B1 (en) * 1996-07-22 2002-01-02 Sankyo Company Limited Neuraminic acid derivatives, their preparation and their medical use
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
TWI291462B (en) 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
EP2792676A4 (en) * 2011-12-16 2015-10-07 Daiichi Sankyo Co Ltd PROCESS FOR PREPARING NEURAMINE ACID DERIVATIVES
CN109232677B (zh) * 2018-10-18 2021-12-28 中国科学院合肥物质科学研究院 一种使n-乙酰神经氨酸水合物转化为n-乙酰神经氨酸的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
AU659501B2 (en) * 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
US5639786A (en) 1992-12-04 1997-06-17 Biota Scientific Management, Pty., Ltd. Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
PL315055A1 (en) 1996-09-30
CN1142820A (zh) 1997-02-12
RU2134690C1 (ru) 1999-08-20
WO1995016680A1 (en) 1995-06-22
AP541A (en) 1996-10-01
NO314759B1 (no) 2003-05-19
SK282972B6 (sk) 2003-01-09
BG63338B1 (bg) 2001-10-31
GB9325841D0 (en) 1994-02-23
CZ169396A3 (en) 1996-11-13
UA46723C2 (uk) 2002-06-17
CN1132829C (zh) 2003-12-31
BG100709A (bg) 1997-01-31
EP0734382B1 (en) 2001-02-21
NZ277789A (en) 1999-04-29
JP3317972B2 (ja) 2002-08-26
CZ289234B6 (cs) 2001-12-12
HU9601642D0 (en) 1996-08-28
DE69426726T2 (de) 2001-06-21
KR100403256B1 (ko) 2004-04-30
SA94150417B1 (ar) 2005-12-18
ES2155517T3 (es) 2001-05-16
NO962545D0 (no) 1996-06-14
OA10325A (en) 1997-10-07
FI962464A (fi) 1996-06-13
US6294572B1 (en) 2001-09-25
NO962545L (no) 1996-06-14
DE69426726D1 (de) 2001-03-29
SI0734382T1 (en) 2001-08-31
FI120453B (fi) 2009-10-30
CA2177990C (en) 2000-04-25
IL112011A0 (en) 1995-03-15
AU689185B2 (en) 1998-03-26
HU221971B1 (hu) 2003-03-28
EG20597A (en) 1999-09-30
IS4240A (is) 1995-06-18
SG46669A1 (en) 1998-02-20
CA2177990A1 (en) 1995-06-22
US20020037865A1 (en) 2002-03-28
TW452577B (en) 2001-09-01
CO4340619A1 (es) 1996-07-30
EP0734382A1 (en) 1996-10-02
BR9408340A (pt) 1997-08-19
AP9600810A0 (en) 1996-07-31
MA23396A1 (fr) 1995-07-01
DK0734382T3 (da) 2001-03-19
HRP941001B1 (en) 2001-06-30
HK1014187A1 (en) 1999-09-24
IL112011A (en) 1998-08-16
PT734382E (pt) 2001-06-29
OA11275A (en) 2002-11-20
ZA9410003B (en) 1995-07-25
PL186384B1 (pl) 2004-01-30
CN1502621A (zh) 2004-06-09
FI962464A0 (fi) 1996-06-13
GR3035681T3 (en) 2001-06-29
RO114792B1 (ro) 1999-07-30
HUT74938A (en) 1997-03-28
HRP941001A2 (en) 1997-06-30
BR1100548KB1 (pt) 2011-11-01
AU1314495A (en) 1995-07-03
ATE199255T1 (de) 2001-03-15
MY116221A (en) 2003-12-31
JPH09506601A (ja) 1997-06-30
SV1994000076A (es) 1995-10-26
AP9400705A0 (en) 1995-01-31
PE31095A1 (es) 1995-10-18
SK78596A3 (en) 1997-03-05

Similar Documents

Publication Publication Date Title
HU9303282D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
EE03474B1 (et) CDCH kristallimodifikatsioon, selle valmistamismeetod ning seda modifikatsiooni sisaldavad farmatseutilised preparaadid
AU1819088A (en) New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
EE03353B1 (et) Kristalne 5-atseetamido-2,3,4,5-tetradesoksü-4-guanidino-D-glütsero-D-galaktonon-2-eenpüranosoonh ape, selle valmistamismeetod ja seda sisaldavad farmatseutilised preparaadid
EE03380B1 (et) Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod
IL100899A0 (en) Beta-amino-alpha-hydroxycarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HUT72308A (en) Thiazolidine derivatives and pharmaceutical composition containing the same, and process for their preparation
HU9303283D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
NO944700D0 (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
IL115685A0 (en) Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
AU7227587A (en) Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL110376A0 (en) Pharmaceutical compositions containing ifetroban and methods for the preparation thereof
HUT71106A (en) Propenoic acid derivatives, pharmaceutical compositions containing them and process for their preparation
AU1114288A (en) N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
AU2974189A (en) Pharmaceutical compositions containing lactams, new substituted lactams and processes for the preparation thereof
AU1122688A (en) Substituted 3,4-dihydro-2h-benzopyrans, processes for their preparation, their use and pharmaceutical products based on these compounds
HUT68774A (en) Heterocyclic iminobismethylenebisphosphonic acid derivatives, process for preparing them, and pharmaceutical preparations containing them
HUT72319A (en) Epoxy-succinic acid derivatives, pharmaceutical compositions containing them and process for their preparation
IL109430A0 (en) Hydroxamic acid derivatives, their preparation and pharmaceutical compositions containing them
IL108920A0 (en) Acyloxyhexanoic acid derivatives and pharmaceutical compositions containing them
IL99389A0 (en) Amino acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GR3000330T3 (en) N,n-bis-(4-fluorophenyl) carbamoyl acetohydroxamic acid and pharmaceutical composition containing it
IL90191A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU625163B2 (en) Dihydrocaffeic acid derivatives and pharmaceutical preparations containing same

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231